Overview

Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Compare ocular tissue levels following topical ocular instillation of 1.5% levofloxacin ophthalmic solution or an active comparator in subjects undergoing cataract surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Santen Inc.
Collaborator:
Vistakon Pharmaceuticals
Treatments:
Fluoroquinolones
Levofloxacin
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ofloxacin
Ophthalmic Solutions
Pharmaceutical Solutions